EBR
Asset Logo

EBR Systems Inc.

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 6.01%
Annual Growth

3 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

7
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. The company is headquartered in Sunnyvale, California. The company went IPO on 2021-11-24. The firm is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The firm also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The firm operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.

📈 Performance

Price History

+17.13%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$1.26

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in EBR

7

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in EBR

488 days
EBR investor breakdown
💵 Income of investors

More than 200k

150k - 200k

14%

100k - 150k

50k - 100k

43%

Less than 50k

43%
👶 Age of investors

18 - 25

14%

26 - 34

35 - 90

86%
🙋 Legal gender of investors

Female

43%

Male

57%

Pearlers who invest in EBR also invest in...

Core Lithium Ltd

CXO

Core Lithium Ltd. is an Australian based mineral exploration company, which engages in the acquisition, exploration, evaluation, and development of copper, gold, uranium, and iron ore properties. The company is headquartered in Adelaide, South Australia. The company went IPO on 2011-02-11. The firm owns and operates Finniss Lithium project, which is located south of Darwin Port in the Northern Territory. The project lies within a prospective area for lithium in the NT, the Bynoe Pegmatite Field, and covers approximately 500 square kilometers (km2) of granted tenements. The project is approximately 88 kilometers (km) by sealed road from Darwin Port, Northern Territory. Its other projects include Shoobridge Lithium, Anningie and Barrow Creek Lithium, Sa Zinc, Jervois Domain, Blueys and Inkheart Lead/Silver, Bynoe Gold, Fitton Uranium, and Napperby Uranium. Shoobridge Lithium project is located approximately 80 km south-southeast of Finniss near Darwin in the Northern Territory. Sa Zinc project covers a total area of approximately 500 km2 in northern South Australia. Jervois Domain project covers three exploration licenses in the central Northern Territory.

📊 Share price

$1.07 AUD
Find Out More

Insurance Australia Group Ltd. engages in underwriting of general insurance and related corporate services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-08-08. The firm operates in Australia and New Zealand. Its segments include Direct Insurance Australia, Intermediated Insurance Australia and New Zealand. Its Direct Insurance Australia segment provides personal lines, and some commercial lines, general insurance products sold directly to customers primarily under the NRMA Insurance, SGIO and SGIC brands, the RACV brand in Victoria (via a distribution relationship and underwriting joint venture with RACV), as well as the CGU Insurance and ROLLiN' Insurance brands. Its Intermediated Insurance Australia segment predominantly provides commercial lines, and some personal lines, general insurance products sold to customers through intermediaries, including brokers, authorized representatives and distribution partners, primarily under the CGU Insurance and WFI brands, as well as the Coles Insurance brand via a distribution agreement with Coles.

📊 Share price

$5.21 AUD

VDHG

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

📊 Share price

$57.36 AUD

NULL GLOBAL

NULL SMART BETA

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

📊 Share price

$43.11 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

Want more shares? Try these...

EBTC

📊 Share price

$4.23 AUD

Elanor Commercial Property Fund is a real estate investment trust investing in commercial office assets. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-12-06. The Fund’s investment property portfolio comprised nine commercial properties in Australia. The Fund’s objective is to provide risk-adjusted returns through a combination of regular distributions and capital growth. The Fund’s investment strategy includes investing in commercial office properties located in metropolitan areas or established commercial precincts; implement leasing and active asset management to grow the income and value of the properties; acquiring additional investment grade commercial properties; and maintain a conservative capital structure with a target Gearing range between 30% and 40%. The firm is managed by Elanor Funds Management Limited.

📊 Share price

$0.87 AUD

EBND

EBND.AX was created on 2020-02-11 by VanEck. The fund's investment portfolio concentrates primarily on broad credit fixed income. EBND.AX aims to provide investors with a globally diversified portfolio of bonds and currencies in emerging markets. The fund aims to provide total investment returns, measured over the medium to long term in excess of the Benchmark

📊 Share price

$10.00 AUD

NULL OTHER

NULL THEMATIC

NULL EX AUSTRALIA

NULL EMERGING

NULL ACTIVE

NULL INCOME

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an Australasian animal care brand owner, product marketer, and distributor. Its segments include Healthcare, Animal Care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, such as own brands, retail healthcare, medical devices, capital equipment, pharmacy services, and wholesale activities. The Animal Care segment incorporates the sale of animal care products in a range of sectors, own brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid, TerryWhite Chemmart, and Pharmacy Wholesalers Russells, among others. Its Contract Logistics business includes Healthcare Logistics and Healthcare Logistics Clinical Trials. Its Institutional Healthcare includes Clinect, Cryomed Aesthetics and Onelink, among others.

📊 Share price

$39.25 AUD
Compare
Add to watchlist